JP2025500342A5 - - Google Patents

Info

Publication number
JP2025500342A5
JP2025500342A5 JP2024537359A JP2024537359A JP2025500342A5 JP 2025500342 A5 JP2025500342 A5 JP 2025500342A5 JP 2024537359 A JP2024537359 A JP 2024537359A JP 2024537359 A JP2024537359 A JP 2024537359A JP 2025500342 A5 JP2025500342 A5 JP 2025500342A5
Authority
JP
Japan
Application number
JP2024537359A
Other languages
Japanese (ja)
Other versions
JP2025500342A (ja
JPWO2023118961A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/000772 external-priority patent/WO2023118961A1/en
Publication of JP2025500342A publication Critical patent/JP2025500342A/ja
Publication of JP2025500342A5 publication Critical patent/JP2025500342A5/ja
Publication of JPWO2023118961A5 publication Critical patent/JPWO2023118961A5/ja
Pending legal-status Critical Current

Links

JP2024537359A 2021-12-21 2022-12-20 極性基を有する毒素を含む抗体薬物コンジュゲート及びその使用 Pending JP2025500342A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163292101P 2021-12-21 2021-12-21
US63/292,101 2021-12-21
PCT/IB2022/000772 WO2023118961A1 (en) 2021-12-21 2022-12-20 Antibody drug conjugates comprising toxins with polar groups and uses thereof

Publications (3)

Publication Number Publication Date
JP2025500342A JP2025500342A (ja) 2025-01-09
JP2025500342A5 true JP2025500342A5 (https=) 2026-01-06
JPWO2023118961A5 JPWO2023118961A5 (https=) 2026-01-06

Family

ID=86766932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537359A Pending JP2025500342A (ja) 2021-12-21 2022-12-20 極性基を有する毒素を含む抗体薬物コンジュゲート及びその使用

Country Status (6)

Country Link
US (1) US20230190939A1 (https=)
EP (1) EP4452328A1 (https=)
JP (1) JP2025500342A (https=)
KR (1) KR20240127409A (https=)
CN (2) CN118414170A (https=)
WO (1) WO2023118961A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210068591A (ko) 2018-10-31 2021-06-09 주식회사 인투셀 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도
US20250239582A1 (en) 2024-01-19 2025-07-24 24M Technologies, Inc. Systems and methods for preparing semi-solid electrodes
WO2025214466A1 (en) * 2024-04-12 2025-10-16 BeiGene Guangzhou Biologics Manufacturing Co., Ltd. Targeted pyrrolobenzodiazapine conjugates
WO2026059501A1 (en) * 2024-09-13 2026-03-19 Hummingbird Bioscience Pte. Ltd. Linker moieties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843937A (en) * 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
US10131682B2 (en) * 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
GB201617466D0 (en) * 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
KR20210068591A (ko) * 2018-10-31 2021-06-09 주식회사 인투셀 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도
KR102503143B1 (ko) * 2019-03-06 2023-02-24 주식회사 레고켐 바이오사이언스 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2025500342A5 (https=)
BR102022025291A2 (https=)
CL2026000109A1 (es) Composiciones farmacéuticas de derivados de la insulina.
CL2025003711S1 (es) Cierre para una estructura de rampas para maniobras vehiculares.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13140U (https=)
BY13149U (https=)
BY13142U (https=)
CN307046121S (https=)
CN307045463S (https=)
BY13153U (https=)
BY13141U (https=)
BY13144U (https=)